首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1288860

全球过敏性免疫疗法市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Allergy Immunotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

据推测，到2030年，全球过敏免疫疗法市场的需求将从2022年的3.27百万美元达到近7.08百万美元，在2023-2030年的研究期间，年复合增长率为13.97%。

过敏免疫疗法是一种医疗手段，用于减少或停止因接触草花粉、屋尘螨和蜂毒等过敏原而引起的过敏发作。典型的治疗方法包括定期注射过敏疫苗，其中含有引发过敏反应的微量过敏原，以刺激免疫系统。根据给药途径的不同，存在不同类型的免疫疗法。这种疗法的有效性取决于治疗方案的长度和过敏原的剂量。

市场动态：

儿童和成人都可以接受过敏性免疫疗法。在使用过敏原免疫疗法治疗老年人时，要考虑到他们原有的医疗条件。过敏原免疫疗法的费用因国家和给药途径而异。污染水平的上升和过敏反应导致的慢性疾病的流行将成为该市场增长的主要动力。与传统方法相比，免疫疗法在治疗不同类型的过敏症，如过敏性鼻炎、过敏性哮喘、结膜炎（眼部过敏）或刺吸式昆虫过敏方面的有效性将有利于该市场的增长。所有年龄组的患者对基于免疫疗法的过敏症治疗的认识和批准不断提高，将促进市场增长。在研究和开发高质量的过敏针剂以涵盖几种已知的过敏原方面，医疗保健投资的增加将成为市场的助推器。该市场增长的主要障碍是缺乏对过敏免疫疗法的认识。

报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。

此外，这些工具还对全球过敏性免疫疗法市场的每个细分市场进行了全面评估。

区域分析：

这一部分涵盖了区域划分，强调了北美、欧洲、亚太、拉美、中东和非洲的过敏免疫疗法市场的当前和未来需求。此外，报告还关注了所有重要地区的个别应用部分的需求。

该研究报告还涵盖了市场上主要参与者的全面概况和对全球竞争格局的深入看法。过敏免疫疗法市场的主要参与者包括Adamis Pharmaceuticals Corporation、ALK-Abello A/S、Allergy Therapeutics、ASIT Biotech、Circassia、DVB Technologies SA、DESENTUM OY、HAL Allergy B.V.、HollisterStier Allergy、LETIPharma、Merck KGaA、Mylan N.V、Stallergenes Greer plc。这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如关键的合併和收购、未来的能力、伙伴关系、财务概况、合作、新产品的开发、新产品的推出以及其他发展。

如果你有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

区域展望
简介
北美洲
- 概述、历史和预测数据
- 北美洲：按细分市场划分
- 北美洲：按国家划分
- 美国
- 加拿大
- 墨西哥
欧洲
- 概述、历史和预测数据
- 按部门分類的欧洲
- 欧洲：按国家划分
- 英国
- 法国
- 德国
- 意大利
- 俄罗斯
- 欧洲其他地区
亚太地区
- 概述、历史和预测数据
- 亚太地区按细分市场划分
- 亚太地区：按国家划分
- 中国
- 印度
- 日本
- 韩国
- 澳大利亚
- 亚太其他地区
拉美地区
- 概述、历史和预测数据
- 按部门分類的拉美地区
- 拉丁美洲：按国家划分
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 拉美其他地区
中东和非洲
- 概述、历史和预测数据
- 中东和非洲，按细分市场划分
- 中东和非洲：按国家分类
- 沙特阿拉伯
- 阿拉伯联合酋长国
- 以色列
- 南非
- 中东和非洲其他地区

第十章：过敏免疫疗法公司的竞争格局

过敏免疫疗法的市场竞争
伙伴关系/合作/协议
合并和收购
新产品发布
其他方面的发展

第十一章：公司简介

公司份额分析
市场集中度
Adamis Pharmaceuticals Corporation
- 公司概况
- 产品
- 近期发展情况
ALK-Abello A/S
- 公司概况
- 产品
- 近期发展
Allergy Therapeutics
- 公司概况
- 产品
- 近期发展
ASIT Biotech
- 公司概况
- 产品
- 近期发展
Circassia
- 公司概况
- 产品
- 近期发展
DVB Technologies SA
- 公司概况
- 产品
- 近期发展
DESENTUM OY
- 公司概况
- 产品
- 近期发展
HAL Allergy B.V.
- 公司概况
- 产品
- 近期发展
HollisterStier Allergy
- 公司概况
- 产品
- 近期发展
LETIPharma
- 公司概况
- 产品
- 近期发展
Merck KGaA
- 公司概况
- 产品
- 近期发展
Mylan N.V.
- 公司概况
- 产品
- 近期发展
Stallergenes Greer plc
- 公司概况
- 产品
- 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

简介目录图表

Product Code: VMR11213853

The global demand for Allergy Immunotherapy Market is presumed to reach the valuation of nearly USD 7.08 MN by 2030 from USD 3.27 MN in 2022 with a CAGR of 13.97% under the study period of 2023-2030.

Allergy immunotherapy is a medical treatment used to reduce or stop allergy attacks caused by exposure to allergens like grass pollens, house dust mites, and bee venom. The typical treatment method involves regular allergy shots containing a tiny amount of the allergens triggering the allergic reactions to stimulate the immune system. Different types of immunotherapy exist based on the administration route. The effectiveness of this therapy depends on the length of the treatment program and the dose of the allergen.

Market Dynamics:

Both children and adults can undergo allergy immunotherapy. While treating older adults using allergy immunotherapy, their pre-existing medical conditions are taken into consideration. The cost of the allergen immunotherapy varies by country and administration route. Rising pollution levels and the prevalence of chronic disorders due to allergic reactions will serve as the main impetus for this market's growth. The effectiveness of immunotherapy in treating different types of allergies like allergic rhinitis, allergic asthma, conjunctivitis (eye allergy), or stinging insect allergy compared to traditional methods will benefit this market's growth. Growing awareness and approval for an immunotherapy-based treatment for allergies in patients of all age groups will boost the market growth. Increased healthcare investments in the research and development of high-quality allergy shots to cover several types of known allergens will be a market booster. The major hurdle for the growth of this market is the lack of awareness about allergy immunotherapy.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of allergy immunotherapy.

Market Segmentation:

This section of the allergy immunotherapy market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Treatment Type

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

By Allergy Type

Allergic Rhinitis
Allergic Asthma
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for Allergy Immunotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the allergy immunotherapy market include Adamis Pharmaceuticals Corporation,ALK-Abello A/S,Allergy Therapeutics,ASIT Biotech,Circassia,DVB Technologies SA,DESENTUM OY,HAL Allergy B.V.,HollisterStier Allergy,LETIPharma,Merck KGaA,Mylan N.V.,Stallergenes Greer plc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ALLERGY IMMUNOTHERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Treatment Type
- 3.7.2 By Allergy Type
- 3.7.3 By Distribution Channel
- 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY TREATMENT TYPE

6.1 Overview by Treatment Type
6.2 Historical and Forecast Data
6.3 Analysis by Treatment Type
6.4 Subcutaneous Immunotherapy (SCIT) Market by Regions
6.6 Sublingual Immunotherapy (SLIT) Market by Regions

7 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY ALLERGY TYPE

7.1 Overview by Allergy Type
7.2 Historical and Forecast Data
7.3 Analysis by Allergy Type
7.4 Allergic rhinitis Market by Regions
7.5 Allergic asthma Market by Regions
7.6 Others Market by Regions

8 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacy Market by Regions
8.5 Retail Pharmacy Market by Regions
8.6 Online Pharmacy Market by Regions

9 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America
- 9.3.1. Overview, Historic and Forecast Data
- 9.3.2. North America By Segment
- 9.3.3. North America By Country
- 9.3.4. United State
- 9.3.5. Canada
- 9.3.6. Mexico
9.4. Europe
- 9.4.1. Overview, Historic and Forecast Data
- 9.4.2. Europe by Segment
- 9.4.3. Europe by Country
- 9.4.4. United Kingdom
- 9.4.5. France
- 9.4.6. Germany
- 9.4.7. Italy
- 9.4.8. Russia
- 9.4.9. Rest Of Europe
9.5. Asia Pacific
- 9.5.1. Overview, Historic and Forecast Data
- 9.5.2. Asia Pacific by Segment
- 9.5.3. Asia Pacific by Country
- 9.5.4. China
- 9.5.5. India
- 9.5.6. Japan
- 9.5.7. South Korea
- 9.5.8. Australia
- 9.5.9. Rest Of Asia Pacific
9.6. Latin America
- 9.6.1. Overview, Historic and Forecast Data
- 9.6.2. Latin America by Segment
- 9.6.3. Latin America by Country
- 9.6.4. Brazil
- 9.6.5. Argentina
- 9.6.6. Peru
- 9.6.7. Chile
- 9.6.8. Rest of Latin America
9.7. Middle East & Africa
- 9.7.1. Overview, Historic and Forecast Data
- 9.7.2. Middle East & Africa by Segment
- 9.7.3. Middle East & Africa by Country
- 9.7.4. Saudi Arabia
- 9.7.5. UAE
- 9.7.6. Israel
- 9.7.7. South Africa
- 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY IMMUNOTHERAPY COMPANIES

10.1. Allergy Immunotherapy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY IMMUNOTHERAPY INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Adamis Pharmaceuticals Corporation
- 11.3.1. Company Overview
- 11.3.2. Financials
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. ALK-Abello A/S
- 11.4.1. Company Overview
- 11.4.2. Financials
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Allergy Therapeutics
- 11.5.1. Company Overview
- 11.5.2. Financials
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. ASIT Biotech
- 11.6.1. Company Overview
- 11.6.2. Financials
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Circassia
- 11.7.1. Company Overview
- 11.7.2. Financials
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. DVB Technologies SA
- 11.8.1. Company Overview
- 11.8.2. Financials
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. DESENTUM OY
- 11.9.1. Company Overview
- 11.9.2. Financials
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. HAL Allergy B.V.
- 11.10.1. Company Overview
- 11.10.2. Financials
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. HollisterStier Allergy
- 11.11.1. Company Overview
- 11.11.2. Financials
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. LETIPharma
- 11.12.1. Company Overview
- 11.12.2. Financials
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Merck KGaA
- 11.13.1. Company Overview
- 11.13.2. Financials
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Mylan N.V.
- 11.14.1. Company Overview
- 11.14.2. Financials
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Stallergenes Greer plc
- 11.15.1. Company Overview
- 11.15.2. Financials
- 11.15.3. Products
- 11.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Treatment Type (USD MN)
Subcutaneous Immunotherapy (SCIT) Market by Geography (USD MN)
Sublingual Immunotherapy (SLIT) Market by Geography (USD MN)
Analysis Market by Allergy Type (USD MN)
Allergic rhinitis Market by Geography (USD MN)
Allergic asthma Market by Geography (USD MN)
Others Market by Geography (USD MN)
Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market by Geography (USD MN)
Retail Pharmacy Market by Geography (USD MN)
Online Pharmacy Market by Geography (USD MN)
Global Allergy Immunotherapy Market by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisiton

LIST OF FIGURES

Research Scope of Allergy Immunotherapy Report
Market Research Process
Market Research Methodology
Global Allergy Immunotherapy Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment Type
Market Attractiveness Analysis by Allergy Type
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Treatment Type (USD MN)
Subcutaneous Immunotherapy (SCIT) Market by Geography (USD MN)
Sublingual Immunotherapy (SLIT) Market by Geography (USD MN)
Global Market Analysis by Allergy Type (USD MN)
Allergic rhinitis Market by Geography (USD MN)
Allergic asthma Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market by Geography (USD MN)
Retail Pharmacy Market by Geography (USD MN)
Online Pharmacy Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

02-2729-4219

+886-2-2729-4219

License/价格

全球过敏性免疫疗法市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测